Vanda Pharmaceuticals
VNDA
VNDA
176 hedge funds and large institutions have $722M invested in Vanda Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 63 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
+13
Holders Change %
+7.98%
% of All Funds
3.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
59
Reduced
63
Closed
15
Calls
$731K
Puts
$2.51M
Net Calls
-$1.78M
Net Calls Change
-$180K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$11.8M |
| 2 |
BlackRock
New York
|
$129M |
| 3 |
Millennium Management
New York
|
$8.46M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
$5.01M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$9.87M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$3.21M |
| 2 |
Renaissance Technologies
New York
|
$52.4M |
| 3 |
SG Americas Securities
New York
|
$133K |
| 4 |
State Street
Boston,
Massachusetts
|
$42.1M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
$1.3M |
